Opportunistic Infections Citation List:
September 30 – October 13, 2011
ANTIFUNGAL COMPOUNDS (includes Cryptococcus, Aspergillus, Candida, & Histoplasma)
1. Synthesis and Anti-Candida Potential of Certain Novel 1-[(3-Substituted-3-phenyl)propyl]-1H-imidazoles. Aboul-Enein, M.N., A.A. El-Azzouny, M.I. Attia, O.A. Saleh, and A.L. Kansoh. Archiv Der Pharmazie, 2011. [Epub ahead of print]; PMID[21987482].
[PubMed]. OI_0930-101311.
2. Influence of Hyaluronic acid on Bacterial and Fungal Species, Including Clinically Relevant Opportunistic Pathogens. Ardizzoni, A., R.G. Neglia, M.C. Baschieri, C. Cermelli, M. Caratozzolo, E. Righi, B. Palmieri, and E. Blasi, Journal of Materials Science. Materials in Medicine, 2011. 22(10): p. 2329-2338; PMID[21892787].
[PubMed]. OI_0930-101311.
3. Synthesis and Biological Evaluation of Antifungal Activities of Novel 1,2-trans Glycosphingolipids. Ding, N., W. Zhang, G. Lv, and Y. Li, Archiv Der Pharmazie, 2011. [Epub ahead of print]; PMID[21987208].
[PubMed]. OI_0930-101311.
4. Design, Synthesis, and Biological Evaluation of 1-[(Biarylmethyl)methylamino]-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)pro pan-2-ols as Potent Antifungal Agents: New Insights into Structure-Activity Relationships. Guillon, R., F. Pagniez, C. Rambaud, C. Picot, M. Duflos, C. Loge, and P. Le Pape, ChemMedChem, 2011. 6(10): p. 1806-1815; PMID[21748853].
[PubMed]. OI_0930-101311.
5. A New Chitosan-thymine Conjugate: Synthesis, Characterization and Biological Activity. Kumar, S., H. Kim, M.K. Gupta, P.K. Dutta, and J. Koh, International Journal of Biological Macromolecules, 2011. [Epub ahead of print]; PMID[21986543].
[PubMed]. OI_0930-101311.
6. Synthesis and Biological Activity of Ethyl 2-(substituted benzylthio)-4-(3'-(ethoxycarbonyl)biphenyl-4-yl)-6-methyl-1,4-dihydropyrimidine-5 -carboxylate Derivatives. Maddila, S. and S.B. Jonnalagadda, Archiv Der Pharmazie, 2011. [Epub ahead of print]; PMID[21987259].
[PubMed]. OI_0930-101311.
7. In Vitro Analyses of the Effect of Heparin and Parabens on Candida albicans Biofilms and Planktonic Cells. Miceli, M.H., S.M. Bernardo, T.S. Ku, C. Walraven, and S.A. Lee, Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]; PMID[21986822].
[PubMed]. OI_0930-101311.
8. Antimicrobial Activity of a New Series of Benzimidazole Derivatives. Ozkay, Y., Y. Tunali, H. Karaca, and I. Isikdag, Archives of Pharmacal Research, 2011. 34(9): p. 1427-1435; PMID[21975803].
[PubMed]. OI_0930-101311.
9. In Vitro Activity of a Novel Broad-spectrum Antifungal, E1210, Tested against Candida spp. as Determined by CLSI Broth Microdilution Method. Pfaller, M.A., K. Hata, R.N. Jones, S.A. Messer, G.J. Moet, and M. Castanheira, Diagnostic Microbiology and Infectious Disease, 2011. 71(2): p. 167-170; PMID[21696907].
[PubMed]. OI_0930-101311.
10. Synthesis and Biological Evaluation of Dihydroindeno and Indeno [1,2-e] [1,2,4]triazolo [3,4-b] [1,3,4]thiadiazines as Antimicrobial Agents. Prakash, O., D.K. Aneja, K. Hussain, P. Lohan, P. Ranjan, S. Arora, C. Sharma, and K.R. Aneja, European Journal of Medicinal Chemistry, 2011. 46(10): p. 5065-5073; PMID[21899929].
[PubMed]. OI_0930-101311.
11. Design, Synthesis and Antifungal Activity of some New Imidazole and Triazole Derivatives. Rezaei, Z., S. Khabnadideh, K. Zomorodian, K. Pakshir, G. Kashi, N. Sanagoei, and S. Gholami, Archiv Der Pharmazie, 2011. 344(10): p. 658-665; PMID[21984016].
[PubMed]. OI_0930-101311.
12. The Quorum-Sensing Molecule Farnesol Is a Modulator of Drug Efflux Mediated by ABC Multidrug Transporters and Synergizes with Drugs in Candida albicans. Sharma, M. and R. Prasad, Antimicrobial Agents and Chemotherapy, 2011. 55(10): p. 4834-4843; PMID[21768514].
[PubMed]. OI_0930-101311.
13. Antimicrobial Properties of Natural Coniferous Rosin in the European Pharmacopoeia Challenge Test. Sipponen, A. and K. Laitinen, APMIS : Acta Pathologica, Microbiologica, et Immunologica Scandinavica, 2011. 119(10): p. 720-724; PMID[21917009].
[PubMed]. OI_0930-101311.
14. Methylxanthine Inhibit Fungal Chitinases and Exhibit Antifungal Activity. Tsirilakis, K., C. Kim, A.G. Vicencio, C. Andrade, A. Casadevall, and D.L. Goldman, Mycopathologia, 2011. [Epub ahead of print]; PMID[21968902].
[PubMed]. OI_0930-101311.
ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)
15. Synthesis of 3-Heteroarylthioquinoline Derivatives and Their in Vitro Antituberculosis and Cytotoxicity Studies. Chitra, S., N. Paul, S. Muthusubramanian, P. Manisankar, P. Yogeeswari, and D. Sriram, European Journal of Medicinal Chemistry, 2011. 46(10): p. 4897-4903; PMID[21855182].
[PubMed]. OI_0930-101311.
16. Comparison of the Bactericidal Activity of Various Fluoroquinolones against Mycobacterium tuberculosis in an in Vitro Experimental Model. Cremades, R., J.C. Rodriguez, E. Garcia-Pachon, A. Galiana, M. Ruiz-Garcia, P. Lopez, and G. Royo, The Journal of Antimicrobial Chemotherapy, 2011. 66(10): p. 2281-2283; PMID[21733966].
[PubMed]. OI_0930-101311.
17. Design and Synthesis of Conformationally Constrained Inhibitors of Non-Nucleoside Reverse Transcriptase. Gomez, R., S. Jolly, T.M. Williams, J.P. Vacca, M. Torrent, G. McGaughey, M.T. Lai, P.J. Felock, V. Munshi, D. Distefano, J.A. Flynn, M.D. Miller, Y. Yan, J.C. Reid, R. Sanchez, Y. Liang, B. Paton, B.L. Wan, and N.J. Anthony, Journal of Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21985673].
[PubMed]. OI_0930-101311.
18. Synthesis and In-Vitro Antimycobacterial Activity of Fluoroquinolone Derivatives Containing a Coumarin Moiety. Guo, Q., M.L. Liu, L.S. Feng, K. Lv, Y. Guan, H.Y. Guo, and C.L. Xiao, Archiv Der Pharmazie, 2011. [Epub ahead of print]; PMID[21989627].
[PubMed]. OI_0930-101311.
19. Design, Synthesis and Docking Studies of Quinoline-oxazolidinone Hybrid Molecules and Their Antitubercular Properties. Thomas, K.D., A.V. Adhikari, I.H. Chowdhury, T. Sandeep, R. Mahmood, B. Bhattacharya, and E. Sumesh, European Journal of Medicinal Chemistry, 2011. 46(10): p. 4834-4845; PMID[21880400].
[PubMed]. OI_0930-101311.
20. Synthesis and Structure-Activity Relationships of Varied Ether Linker Analogues of the Antitubercular Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1, 3]oxazine (PA-824). Thompson, A.M., H.S. Sutherland, B.D. Palmer, I. Kmentova, A. Blaser, S.G. Franzblau, B. Wan, Y. Wang, Z. Ma, and W.A. Denny, Journal of Medicinal Chemistry, 2011. 54(19): p. 6563-6585; PMID[21846109].
[PubMed]. OI_0930-101311.
21. New Fluorine-containing Hydrazones Active against MDR-Tuberculosis. Vavrikova, E., S. Polanc, M. Kocevar, K. Horvati, S. Bosze, J. Stolarikova, K. Vavrova, and J. Vinsova, European Journal of Medicinal chemistry, 2011. 46(10): p. 4937-4945; PMID[21855181].
[PubMed]. OI_0930-101311.
ANTIMALARIAL COMPOUNDS (Plasmodium spp.)
22. In Vitro Anti-plasmodial Activity of Dicoma anomala subsp. gerrardii (Asteraceae): Identification of Its Main Active Constituent, Structure-Activity Relationship Studies and Gene Expression Profiling. Becker, J.V., M.M. van der Merwe, A.C. Van Brummelen, P. Pillay, B.G. Crampton, E.M. Mmutlane, C. Parkinson, F.R. van Heerden, N.R. Crouch, P.J. Smith, D.T. Mancama, and V.J. Maharaj, Malaria Journal, 2011. 10(1): p. 295; PMID[21985233].
[PubMed]. OI_0930-101311.
23. Synthesis and Biological Evaluation of Some Pyrazole Derivatives as Anti-Malarial Agents. Bekhit, A.A., A. Hymete, H. Asfaw, and A.E. Bekhit, Archiv Der Pharmazie, 2011. [Epub ahead of print]; PMID[21989651].
[PubMed]. OI_0930-101311.
24. Antimalarial beta-Carboline and Indolactam Alkaloids from Marinactinospora thermotolerans , a Deep Sea Isolate. Huang, H., Y. Yao, Z. He, T. Yang, J. Ma, X. Tian, Y. Li, C. Huang, X. Chen, W. Li, S. Zhang, C. Zhang, and J. Ju, Journal of Natural Products, 2011. [Epub ahead of print]; PMID[21977916].
[PubMed]. OI_0930-101311.
25. Structure and in Vitro Antiparasitic Activity of Constituents of Citropsis articulata Root Bark. Lacroix, D., S. Prado, D. Kamoga, J. Kasenene, and B. Bodo, Journal of Natural Products, 2011. [Epub ahead of print]; PMID[21985060].
[PubMed]. OI_0930-101311.
26. CNS and Antimalarial Activity of Synthetic Meridianin and Psammopemmin Analogs. Lebar, M.D., K.N. Hahn, T. Mutka, P. Maignan, J.B. McClintock, C.D. Amsler, A. van Olphen, D.E. Kyle, and B.J. Baker, Bioorganic & Medicinal Chemistry, 2011. 19(19): p. 5756-5762; PMID[21907583].
[PubMed]. OI_0930-101311.
27. Optimization of Propafenone Analogues as Antimalarial Leads. Lowes, D.J., W.A. Guiguemde, M.C. Connelly, F. Zhu, M.S. Sigal, J.A. Clark, A.S. Lemoff, J.L. Derisi, E.B. Wilson, and R.K. Guy, Journal of Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21955244].
[PubMed]. OI_0930-101311.
28. Cyclopropyl Carboxamides a Novel Chemical Class of Antimalarial Agents Identified in a Phenotypic Screen. Sanz, L.M., M.B. Jimenez-Diaz, B. Crespo, C. De-Cozar, M.J. Almela, I. Angulo-Barturen, P. Castaneda, J. Ibanez, E.P. Fernandez, S. Ferrer, E. Herreros, S. Lozano, M.S. Martinez, L. Rueda, J.N. Burrows, J.F. Garcia-Bustos, and F.J. Gamo, Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]; PMID[21968362].
[PubMed]. OI_0930-101311.
29. Synthesis and in Vitro Antiprotozoal Activities of 5-Phenyliminobenzo[a]phenoxazine Derivatives. Shi, X.L., J.F. Ge, B.Q. Liu, M. Kaiser, S. Wittlin, R. Brun, and M. Ihara, Bioorganic & Medicinal Chemistry Letters, 2011. 21(19): p. 5804-5807; PMID[21868222].
[PubMed]. OI_0930-101311.
30. 4-Thiophenoxy-2-trichloromethyquinazolines Display in Vitro Selective Antiplasmodial Activity against the Human Malaria Parasite Plasmodium falciparum. Verhaeghe, P., A. Dumetre, C. Castera-Ducros, S. Hutter, M. Laget, C. Fersing, M. Prieri, J. Yzombard, F. Sifredi, S. Rault, P. Rathelot, P. Vanelle, and N. Azas, Bioorganic & Medicinal Chemistry Letters, 2011. 21(19): p. 6003-6006; PMID[21852132].
[PubMed]. OI_0930-101311.
31. Quinoline Antimalarials Containing a Dibemethin Group Are Active against Chloroquinone-Resistant Plasmodium falciparum and Inhibit Chloroquine Transport via the P. falciparum Chloroquine-Resistance Transporter (PfCRT). Zishiri, V.K., M.C. Joshi, R. Hunter, K. Chibale, P.J. Smith, R.L. Summers, R.E. Martin, and T.J. Egan, Journal of Medicinal Chemistry, 2011. 54(19): p. 6956-6968; PMID[21875063].
[PubMed]. OI_0930-101311.
ANTILEISHMANIAL COMPOUNDS (Leishmania spp.)
32. New Cassane Diterpenes from Caesalpinia echinata. Cota, B.B., D.M. de Oliveira, E.P. de Siqueira, E.M. Souza-Fagundes, A.M. Pimenta, D.M. Santos, A. Rabello, and C.L. Zani, Fitoterapia, 2011. 82(7): p. 969-975; PMID[21641971].
[PubMed]. OI_0930-101311.
33. In Vitro and in Vivo Studies of the Utility of Dimethyl and Diethyl carbaporphyrin ketals in Treatment of Cutaneous Leishmaniasis. Taylor, V.M., D.L. Cedeno, D.L. Munoz, M.A. Jones, T.D. Lash, A.M. Young, M.H. Constantino, N. Esposito, I.D. Velez, and S.M. Robledo, Antimicrobial Agents and Chemotherapy, 2011. 55(10): p. 4755-4764; PMID[21788471].
[PubMed]. OI_0930-101311.
Citations from the ISI Web of Knowledge Listings for O.I.
34. Hybrid Compounds of Ent-beyerane diterpenoid isosteviol with Pyridinecarboxylic acid hydrazides. Synthesis, Structure, and Antitubercular Activity. Andreeva, O.V., R.R. Sharipova, I.Y. Strobykina, O.A. Lodochnikova, A.B. Dobrynin, V.M. Babaev, R.V. Chestnova, V.F. Mironov, and V.E. Kataev. Russian Journal of General Chemistry, 2011. 81(8): p. 1643-1650; ISI[000295040600011].
[WOS]. OI_0930-101311.
Byrsonima fagifolia Niedenzu Apolar Compounds with Antitubercular Activity. Higuchi, C.T., M. Sannomiya, F.R. Pavan, S.R. Leite, D.N. Sato, S.G. Franzblau, L.V. Sacramento, W. Vilegas, and C.Q. Leite. Evidence-Based Complementary and Alternative Medicine, 2011. 1741-427X; ISI[000293355700001].
OI_0930-101311.
36. Detailed Comparison of Candida albicans and Candida glabrata Biofilms under Different Conditions and Their Susceptibility to Caspofungin and Anidulafungin. Kucharikova, S. H. Tournu, K. Lagrou, P. Van Dijck, and H. Bujdakova. Journal of Medical Microbiology, 2011. 60(9): p. 1261-1269; ISI[000295018700005].
[WOS]. OI_0930-101311.
37. Design, Synthesis, and Evaluation of Thiazolidinone Derivatives as Antimicrobial and Anti-viral Agents. Ravichandran, V., A. Jain, K.S. Kumar, H. Rajak, and R.K. Agrawal. Chemical Biology & Drug Design, 2011. 78(3): p. 464-470; ISI[000294990900014].
[WOS]. OI_0930-101311.
38. Efficacy of Zosteric Acid Sodium Salt on the Yeast Biofilm Model Candida albicans. Villa, F., B. Pitts, P.S. Stewart, B. Giussani, S. Roncoroni, D. Albanese, C. Giordano, M. Tunesi, and F. Cappitelli. Microbial Ecology, 2011. 62(3): p. 584-598; ISI[000294963300009].
[WOS]. OI_0930-101311.